Home/Lineage Cell Therapeutics/Dipti Amin, MBBS

DA

Dipti Amin, MBBS

Director

Lineage Cell Therapeutics

Therapeutic Areas

Neurology Ophthalmology Oncology

Lineage Cell Therapeutics Pipeline

Drug	Indication	Phase
OPC1	Acute Spinal Cord Injury	Phase 1/2a
OpRegen	Geographic Atrophy secondary to Age-related Macular Degeneration	Phase 1/2a
ANP1	Sensorineural Hearing Loss	Preclinical
VAC2	Non-small Cell Lung Cancer	Phase 1

Leadership Team at Lineage Cell Therapeutics

Chief Executive Officer

Chief Financial Officer

George A. Samuel III

General Counsel & Corporate Secretary

Vice President of Business Development

Jennifer Bahr-Davidson, Ph.D.

Vice President of Technical Operations

Charlotte Hubbert, Ph.D.

Vice President, Corporate Strategy and Development

Rami Skaliter, M.Sc., Ph.D.

Chief Executive Officer, Cell Cure Neurosciences

Michael H. Mulroy

Chairman of the Board

View full Lineage Cell Therapeutics profile